Related Experiment Video
Updated: May 8, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Compounded treatments for erectile dysfunction: a common complication of diabetes
1Innovative Pharmacy Solution, Edmond, Oklahoma.
International Journal of Pharmaceutical Compounding
|August 27, 2013
Summary
Erectile dysfunction is common in men with diabetes, often caused by uncontrolled blood sugar. Specialized compounded medications, guided by physicians and pharmacists, offer a viable treatment option.
Area of Science:
- Endocrinology
- Urology
- Pharmacology
Background:
- Erectile dysfunction (ED) significantly impacts men with diabetes mellitus, affecting 50-80% of this population.
- Diabetic ED is frequently linked to vascular and autonomic nervous system complications arising from hyperglycemia.
- Existing treatment modalities for ED in diabetic patients require optimization.
Purpose of the Study:
- To highlight the prevalence and underlying mechanisms of erectile dysfunction in diabetic patients.
- To explore the role of compounding in creating specialized medication formulations for ED treatment.
- To emphasize the collaborative approach between physicians and compounding pharmacists for successful ED management.
Main Methods:
- Review of existing literature on diabetes, erectile dysfunction, and treatment strategies.
- Analysis of the benefits of compounded medications in addressing specific patient needs.
- Emphasis on the importance of physician-pharmacist collaboration in treatment planning.
Main Results:
- Erectile dysfunction is a prevalent complication in men with diabetes mellitus.
- Vascular and autonomic dysfunction due to hyperglycemia are primary contributors to diabetic ED.
- Compounded medications offer tailored dosage forms for effective ED treatment.
Conclusions:
- Successful management of erectile dysfunction in diabetic patients is achievable through a combination of medical expertise and pharmaceutical compounding.
- Personalized treatment strategies utilizing compounded medications can improve patient outcomes.
- Collaboration between healthcare providers is crucial for optimizing ED therapy in the context of diabetes.
Related Concept Videos
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...